Global Market Research Group

Albany, New York, Feb 24, 2017 "MDNA Life Sciences Inc - Product Pipeline Analysis, 2017 Update" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome for biomarker discovery, early disease detection, monitoring, risk assessment and therapeutic targeting. Its Prostate Core Mitomic Test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and other cancers. The company provides Skin Physical and Skin Care Mitomic Tests by utilizing mtDNA-based biomarkers, to the skin care field. MDNAs target therapy areas include prostate cancer, pancreatic cancer, lung cancer, ovarian cancer, and endometriosis. It provides services to patients, medical providers and manufacturers of skin and sun care products. MDNA